Publications by authors named "Martin Backer"

Claim this Profile
M
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
Robert L Atmar, Kirsten E Lyke, Christine M Posavad, Meagan E Deming, Rebecca C Brady

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Youyi Fong, Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen

Clin Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Bo Zhang, Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Nadine G Rouphael, Angela R Branche, David J Diemert, Ann R Falsey, Cecilia Losada

J Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Angela R Branche, Nadine G Rouphael, David J Diemert, Ann R Falsey, Cecilia Losada

Nat Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson

Clin Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
Kirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, Christine M Posavad, Meagan E Deming

NPJ Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Nadine G Rouphael, Angela R Branche, David J Diemert, Ann R Falsey, Cecilia Losada

medRxiv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.
Angela Branche, Nadine Rouphael, David Diemert, Ann Falsey, Cecilia Losada, Martin Backer

Res Sq· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson

medRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action.
Erin M Scherer, Martin Backer, Karen Carvajal, Lara Danziger-Isakov, Sharon Frey

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Kirsten E Lyke, Robert L Atmar, Clara Dominguez Islas, Christine M Posavad, Daniel Szydlo

Cell Rep Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
Angela R Branche, Nadine G Rouphael, David J Diemert, Ann R Falsey, Cecilia Losada

medRxiv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Children Lagging with COVID-19 Vaccination.
Asif Noor, Martin Backer, Leonard R Krilov

Pediatr Ann· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous and Heterologous Covid-19 Booster Vaccinations.
Robert L Atmar, Kirsten E Lyke, Meagan E Deming, Lisa A Jackson, Angela R Branche

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous SARS-CoV-2 Booster Vaccinations - Preliminary Report.
Robert L Atmar, Kirsten E Lyke, Meagan E Deming, Lisa A Jackson, Angela R Branche

medRxiv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients.
Robert J Ulrich, Andrea B Troxel, Ellie Carmody, Jaishvi Eapen, Martin Bäcker

Open Forum Infect Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Fistula Initiative: Reducing Bloodstream Infections in an Outpatient Pediatric Hemodialysis Center.
Kobkul Chotikanatis, Nisha Suman, Martin Bäcker, Bandana Paudyal, Morris Schoeneman

J Pediatric Infect Dis Soc· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector.
Xinsheng Zhang, Olivia Wallace, Kevin J Wright, Martin Backer, John W Coleman

Virology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
David Landman, Elizabeth Babu, Neha Shah, Paul Kelly, Olafisoye Olawole

J Antimicrob Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
John Quale, Neha Shah, Paul Kelly, Elizabeth Babu, Martin Backer

Microb Drug Resist· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patient.
Kobkul Chotikanatis, Martin Bäcker, Gabriela Rosas-Garcia, Margaret R Hammerschlag

J Clin Microbiol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City.
David Landman, Paul Kelly, Martin Bäcker, Elizabeth Babu, Neha Shah

J Antimicrob Chemother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.
David Landman, Carl Urban, Martin Bäcker, Paul Kelly, Neha Shah

J Clin Microbiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City.
David Landman, Elizabeth Babu, Neha Shah, Paul Kelly, Martin Bäcker

J Antimicrob Chemother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis